BROWSE·page 1080 of 1417

Browse EX-10 agreements

16,999 total material contract exhibits.


EX-10.10

LINCOLN BANCORP /IA/

Document

Exhibit 10.10

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”) is made and entered into this  3rd  day of    April    2015, by and between Lincoln Savings Bank (“Employer”) and Dan Downs (“Employee”).

RECITALS:

Employer wishes to employ Employee under the terms and conditions contained in this Agreement and Employee agrees to accept such employment. This Agreement shall become effective on ___________, 2015.

NOW, THEREFORE, in consideration of the premises and the promises and covenants set forth in this Agreement, the parties agree as follows:

…

EX-10.10·S-1·CIK 906205·ACC 0001628280-26-045588·Filed Jun 25, 2026, 17:02 ET

EX-10.11

LINCOLN BANCORP /IA/

Document

Exhibit 10.11

LINCOLN BANCORP

2019 EQUITY INCENTIVE PLAN

Article 1

INTRODUCTION

Section 1.1    Purpose, Effective Date and Term. The purpose of this Lincoln Bancorp 2019 Equity Incentive Plan is to promote the long-term financial success of Lincoln Bancorp and its Subsidiaries by providing a means to attract, retain and reward individuals who can and do contribute to such success, and to further align their interests with those of the Shareholders. The “Effective Date” of the Plan is April 5, 2019, the date of the approval of the Plan by the Shareholders. The Plan shall remain in effect as long as any Awards are outstanding; provided, however, that no Awards may be granted after the 10-year anniversary of the Effective Date.

…

EX-10.11·S-1·CIK 906205·ACC 0001628280-26-045588·Filed Jun 25, 2026, 17:02 ET

EX-10.3

SharonAI Holdings Inc.

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 17, 2026, by and among SharonAI Holdings Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

…

EX-10.3·8-K·CIK 2068385·ACC 0001493152-26-030158·Filed Jun 25, 2026, 17:00 ET

EX-10.1

Fabric.AI, Inc.

FIFTH AMENDMENT TO

FABRIC.AI, INC. 2020 LONG-TERM INCENTIVE PLAN

 

This FIFTH AMENDMENT TO FABRIC.AI, INC. 2020 LONG-TERM INCENTIVE PLAN (this “Amendment”), effective as of June 18, 2026, is made and entered into by Fabric.AI, Inc., a Delaware corporation (the “Company”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Fabric.AI, Inc. Long-Term Incentive Plan, as amended (collectively, the “Plan”).

 

RECITALS

 

WHEREAS, Article 9 of the Plan provides that the Board of Directors of the Company (the “Board”) may amend the Plan at any time and from time to time;

 

WHEREAS, the Board desires to amend the Plan to increase the aggregate number of shares of Common Stock that may be issued under the Plan, as set forth in Article 5 of the Plan, by an additional 4,600,000 shares of Common Stock; and

 

WHEREAS, the Board intends to submit this Amendment to the Company’s stockholders for their approval.

…

EX-10.1·8-K·CIK 1086745·ACC 0001493152-26-030157·Filed Jun 25, 2026, 17:00 ET

EX-10.1

LIGAND PHARMACEUTICALS INC

Bidding Form: 6/20/2026

[Dealer Name ]

[Dealer Address]

June [____], 2026

To: Ligand Pharmaceuticals Incorporated

555 Heritage Drive, Suite 200

Jupiter FL, 33458

Re: [Base]1[Additional]2 Call Option Transaction

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [Dealer] (“Dealer”) and Ligand Pharmaceuticals Incorporated (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below.

…

EX-10.1·8-K·CIK 886163·ACC 0001193125-26-282990·Filed Jun 25, 2026, 17:00 ET

EX-10.2

LIGAND PHARMACEUTICALS INC

Bidding Form: 6/22/2026

THE SECURITIES REPRESENTED HEREBY (THE “WARRANTS”) WERE ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE WARRANTS MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS THEREOF.

[Dealer Name]

[Dealer Address]

June [__], 2026

To: Ligand Pharmaceuticals Incorporated

555 Heritage Drive, Suite 200

Jupiter, FL 33458

 

Re:

[Base]1[Additional]2 Warrants

…

EX-10.2·8-K·CIK 886163·ACC 0001193125-26-282990·Filed Jun 25, 2026, 17:00 ET

EXHIBIT 10.9

Texas Precious Metals Trust

FORM OF PLATFORM SERVICES AGREEMENT

 

This Platform Services and Support Agreement (the “Agreement”) is made and entered into by and among [Teucrium Asset Management, LLC] (“Teucrium”), and [ ] (“Client”), effective as of [ ], 20[ ] (the “Effective Date”). Teucrium and Client are hereinafter also referred to generically and individually as a “Party” or collectively as the “Parties.”

 

RECITALS

 

WHEREAS, on [ ], 20[ ], for purposes of executing the Project, Teucrium caused a Delaware statutory trust named [ ] (the “Trust”) to be formed;

 

WHEREAS, Teucrium serves as sponsor of the Trust pursuant to that certain Declaration of Trust and Trust Agreement dated effective as of [ ], 20[ ] (as amended or restated from time to time, the “Trust Agreement”);

…

EX-10.9·S-1/A·CIK 2087989·ACC 0001437749-26-021713·Filed Jun 25, 2026, 16:59 ET

EX-10.24

Capstone Energy Plus, Inc.

Execution Version June 23, 2025 VIA EMAIL Capstone Green Energy LLC 16640 Stagg Street Van Nuys, CA 91406 Attention: John Juric, Chief Financial Officer Email: JJuric@CGRNenergy.com With a copy to: Katten Muchin Rosenman LLP 525 W. Monroe Street Chicago, IL 60661-3693 Attention: Mark D. Wood, Esq. and Jaime T. Willis, Esq. Email: mark.wood@katten.com and jaime.willis@katten.com Ladies and Gentlemen: Reference is made to that certain Note Purchase Agreement, dated as of December 7, 2023, by and among Capstone Green Energy LLC as Company, Capstone Green Energy Holdings, Inc. and Capstone Turbine Financial Services, LLC, as Guarantors, the various Purchasers party thereto from time to time and Goldman Sachs Specialty Lending Group, L.P., as Collateral Agent (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement;” capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Note Purchase Agreement). The Company has requested that the Purchaser delay the commencement o

…

EX-10.24·10-K·CIK 1009759·ACC 0001104659-26-077817·Filed Jun 25, 2026, 16:58 ET

EX-10.1

TerrAscend Corp.

[UNLESS PERMITTED UNDER APPLICABLE SECURITIES LEGISLATION, THE HOLDER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE COMMON SHARES, IF ANY, ISSUABLE UPON CONVERSION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE, AND ANY COMMON SHARES ISSUABLE AS INTEREST THEREON, MUST NOT TRADE ANY OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE OR COMMON SHARES ISSUABLE UPON CONVERSION THEREOF, AND ANY COMMON SHARES ISSUABLE AS INTEREST THEREON, BEFORE [INSERT DATE THAT IS 4 MONTHS AND 1 DAY AFTER THE CLOSING DATE].] 1

…

EX-10.1·8-K·CIK 1778129·ACC 0001193125-26-282981·Filed Jun 25, 2026, 16:58 ET

EX-10.1

Blue Owl Real Estate Net Lease Trust

Document

Exhibit 10.1

FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

THIS FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of June 18, 2026 (this “Agreement”), is by and among BLUE OWL NLT OPERATING PARTNERSHIP LP (f/k/a OAKTRUST OPERATING PARTNERSHIP L.P.), a Delaware limited partnership (the “Borrower”), the other Loan Parties (as defined in the Credit Agreement (defined below)) solely for purpose of Section V hereof, KEYBANK NATIONAL ASSOCIATION, as Agent for the Lenders (in such capacity, the “Agent”), and the Lenders (defined below) party hereto.

RECITALS

        WHEREAS, the Borrower, the lenders from time to time party thereto (the “Lenders”) and the Agent are parties to the Amended and Restated Credit Agreement, dated as of June 12, 2025 (as amended, restated, modified or supplemented prior to the date hereof, the “Credit Agreement”); and

…

EX-10.1·8-K·CIK 1944366·ACC 0001944366-26-000046·Filed Jun 25, 2026, 16:57 ET

EX-10.4

Pulsenmore Ltd.

June 25, 2026

 

Pulsenmore Ltd.

Attn: Dr. Elazar Sonnenschein, Chief Executive Officer

8 Omarim St.

Omer, 8496500 Israel

 

Dear Mr. Sonnenschein:

 

This letter (the “Agreement”) constitutes the agreement between A.G.P./Alliance Global Partners (the “Placement Agent”) and Pulsenmore Ltd., a company organized under the laws of the State of Israel (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of (i) shares (the “Shares”) of the Company’s Ordinary Shares, par value NIS 0.00032 per share (the “Ordinary Shares”) and/or pre-funded warrants to purchase Ordinary Shares (the “Pre-Funded Warrants”), depending on the beneficial ownership percentage of the purchaser of the Ordinary Shares following its purchase; and (ii) warrants to purchase Ordinary Shares of the Company (the “Ordinary Warrants”, and together with the Ordinary Warrants, the “Warrants,” and collectively with the Shares, the “**Secur

…

EX-10.4·6-K·CIK 2064764·ACC 0001493152-26-030145·Filed Jun 25, 2026, 16:44 ET

EX-10.1

Pulsenmore Ltd.

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 25, 2026, between Pulsenmore Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act (as defined below) contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.1·6-K·CIK 2064764·ACC 0001493152-26-030145·Filed Jun 25, 2026, 16:44 ET